Exosomm

Exosomm

Develops a food formula for medical purposes, containing patent-based milk exosomes for patients with inflammatory bowel diseases (IBD).

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
*

$100k

Seed
Total Funding000k
More about Exosomm
Made with AI
Edit

Exosomm is an advanced BioTech FoodTech startup focused on developing nutritional solutions based on natural milk-derived exosomes. These exosomes are nano molecules found in mammalian milk that offer significant health benefits, particularly in enhancing human immunity. The company has created a patented food formula specifically designed for medical purposes, targeting patients with inflammatory bowel diseases (IBD). Inspired by the unique health properties of mother's milk, Exosomm employs an efficient and environmentally friendly process to isolate these beneficial exosomes. The primary market for Exosomm's products includes healthcare providers and patients suffering from IBD, a condition characterized by chronic inflammation of the digestive tract. The business model revolves around the sale of these specialized nutritional products, generating revenue through direct sales to healthcare institutions and possibly through partnerships with pharmaceutical companies. By focusing on a niche market with high medical needs, Exosomm aims to improve the quality of life and disease outcomes for its clients.

Keywords: BioTech, FoodTech, exosomes, inflammatory bowel disease, IBD, nutritional solutions, health benefits, immunity, medical purposes, patented formula.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads